checkAd

     602  0 Kommentare Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018 - Seite 2



     

    Approval and publication of the tender offer documents and response by Ablynx's board of directors

     

    Belgian Offer

     

    On March 27, 2018, the Belgian Financial Markets and Services Authority ("FSMA") has approved Sanofi's prospectus relating to the Belgian Offer ("Prospectus") and the response memorandum of the board of directors of Ablynx ("Response Memorandum").

     

    As of April 3, 2018, an electronic version of the Prospectus and its summary shall be available on the websites of the Centralizing Receiving Agents (for BNP Paribas Fortis NV/SA, https://www.bnpparibasfortis.be/epargneretplacer (French and English) and https://www.bnpparibasfortis.be/sparenenbeleggen (Dutch and English); for KBC Securities NV/SA in cooperation with KBC Bank NV/SA,
    https://www.kbcsecurities.com/prospectus-documents-overviews/prospectu ..., https://www.kbc.be, https://www.cbc.be and https://www.bolero.be), Sanofi (https://www.sanofi.com/en/investors/tender-offers-ablynx and https://www.sanofi.com/fr/investisseurs/offres-ablynx) and Ablynx (http://www.ablynx.com/investors/sanofi-takeover-bid/).

     

    The Prospectus is available in English and in Dutch. A French translation of the summary of the Prospectus and Forms is also available.

     

    Hard copies of such documents are available free of charge (i) at the counters of the Centralizing Receiving Agents or (ii) by phoning the Centralizing Receiving Agents at +32 (0)2 433 41 13 (BNP Paribas Fortis NV/SA), +32 (0)78 15 21 53 (KBC Bank NV/SA, Dutch & English), +32 (0) 800 92 020 (CBC Banque NV/SA, French & English) or +32 32 83 29 81 (Bolero by KBC Securities NV/SA, Dutch, French & English).

     

    The Response Memorandum will be appended to the Prospectus.

     

    U.S. Offer

     

    On April 4, 2018, Sanofi will file with the U.S. Securities and Exchange Commission (the "SEC") a Tender Offer Statement on Schedule TO and Ablynx will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with respect to the U.S. Offer.

     

    Initial acceptance period

     

    The initial acceptance period of the tender offers will commence on April 4, 2018 and will expire at 5:00 p.m. ET / 11:00 p.m. CET on May 4, 2018, subject to extension.
    Seite 2 von 5



    Diskutieren Sie über die enthaltenen Werte



    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018 - Seite 2   Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY)Source: Ablynx (Euronext Brussels and Nasdaq: ABLX)     Previously announced Tender Offers by Sanofi to acquire Ablynx will commence on April 4, 2018 Prospectus approved by the …

    Schreibe Deinen Kommentar

    Disclaimer